| Title | Download |
|---|---|
| Ciprofloxacin LCA Study | |
| Investor Grievance Mechanism | |
| TCFD progress report FY24 | |
| Global Tax Policy | |
| Position on Policy Advocacy | |
| Commitment to Biodiversity conservation & No deforestation | |
| ESG Data profile and Supplementary ESG Information_FY24 | |
| GHG Emissions calculations - Methodology |
